Status:
COMPLETED
Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast Cancer
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-60 years
Phase:
PHASE2
Brief Summary
The study will include 27 patients to study the dosimetric data and acute toxicity. Patients will be treated by SIB intensity modulated radiotherapy (IMRT) boost to the cavity.The dose to be delivered...
Detailed Description
Aim To study the dose to the target and OARs with SIB-IMRT in patients with breast cancer. Objectives: To study 1. Dose distribution, target coverage and dose homogeneity in the diseased breast. 2. ...
Eligibility Criteria
Inclusion
- Primary cancer of breast of any histology,
- age 18-60 years,
- post BCS,
- KPS \>70,
- no distant metastasis and patients who have or have not received chemotherapy
Exclusion
- History of prior primary malignancy,
- prior irradiation to breast or chest,
- pregnant or lactating women, and
- collagen vascular disease
Key Trial Info
Start Date :
August 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04072718
Start Date
August 10 2017
End Date
March 31 2020
Last Update
July 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Budhi Singh Yadav
Chandigarh, India, 160012